Connection

Gyorgy Snell to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Gyorgy Snell has written about Drug Evaluation, Preclinical.
Gyorgy Snell
Connection Strength
0.038
Drug Evaluation, Preclinical
  1. Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile. Bioorg Med Chem. 2018 07 23; 26(12):3261-3286.
    View in: PubMed
    Score: 0.019
  2. Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design. Bioorg Med Chem. 2017 09 01; 25(17):4876-4886.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.